List of Tables
    Table 1. Pomalidomide CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Pomalidomide Market Trends
    Table 3. Pomalidomide Market Drivers
    Table 4. Pomalidomide Market Challenges
    Table 5. Pomalidomide Market Restraints
    Table 6. Global Pomalidomide Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Pomalidomide Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Pomalidomide Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Pomalidomide Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Pomalidomide Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Pomalidomide Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Pomalidomide Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Pomalidomide Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Pomalidomide Sales Share by Manufacturer, 2017-2022
    Table 15. Global Pomalidomide Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Pomalidomide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Pomalidomide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pomalidomide as of 2021)
    Table 18. Top Players of Pomalidomide in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Pomalidomide Product Type
    Table 20. Date of International Manufacturers Enter into Pomalidomide Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Pomalidomide Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Pomalidomide Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Pomalidomide Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Pomalidomide Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Pomalidomide Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Pomalidomide Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Pomalidomide Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Pomalidomide Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Pomalidomide Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Pomalidomide Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Pomalidomide Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Pomalidomide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Pomalidomide Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Pomalidomide Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Pomalidomide Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Pomalidomide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Pomalidomide Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Pomalidomide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Pomalidomide Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Pomalidomide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Celgene Corporation Information
    Table 43. Celgene Description and Business Overview
    Table 44. Celgene Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Celgene Pomalidomide Product
    Table 46. Celgene Recent Development
    Table 47. Natco Pharma Corporation Information
    Table 48. Natco Pharma Description and Business Overview
    Table 49. Natco Pharma Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Natco Pharma Product
    Table 51. Natco Pharma Recent Development
    Table 52. Intas Pharmaceuticals Corporation Information
    Table 53. Intas Pharmaceuticals Description and Business Overview
    Table 54. Intas Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Intas Pharmaceuticals Product
    Table 56. Intas Pharmaceuticals Recent Development
    Table 57. Indiabulls Pharmaceutical Corporation Information
    Table 58. Indiabulls Pharmaceutical Description and Business Overview
    Table 59. Indiabulls Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Indiabulls Pharmaceutical Product
    Table 61. Indiabulls Pharmaceutical Recent Development
    Table 62. Cipla Corporation Information
    Table 63. Cipla Description and Business Overview
    Table 64. Cipla Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Cipla Product
    Table 66. Cipla Recent Development
    Table 67. Glenmark Pharmaceuticals Corporation Information
    Table 68. Glenmark Pharmaceuticals Description and Business Overview
    Table 69. Glenmark Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Glenmark Pharmaceuticals Product
    Table 71. Glenmark Pharmaceuticals Recent Development
    Table 72. Dr Reddy's Laboratories Corporation Information
    Table 73. Dr Reddy's Laboratories Description and Business Overview
    Table 74. Dr Reddy's Laboratories Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Dr Reddy's Laboratories Product
    Table 76. Dr Reddy's Laboratories Recent Development
    Table 77. Qilu Pharmaceutical Corporation Information
    Table 78. Qilu Pharmaceutical Description and Business Overview
    Table 79. Qilu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Qilu Pharmaceutical Product
    Table 81. Qilu Pharmaceutical Recent Development
    Table 82. Chia Tai-Tianqing Corporation Information
    Table 83. Chia Tai-Tianqing Description and Business Overview
    Table 84. Chia Tai-Tianqing Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Chia Tai-Tianqing Product
    Table 86. Chia Tai-Tianqing Recent Development
    Table 87. Hanson Pharm Corporation Information
    Table 88. Hanson Pharm Description and Business Overview
    Table 89. Hanson Pharm Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Hanson Pharm Product
    Table 91. Hanson Pharm Recent Development
    Table 92. Meidakang Huakang Pharmaceutical Corporation Information
    Table 93. Meidakang Huakang Pharmaceutical Description and Business Overview
    Table 94. Meidakang Huakang Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Meidakang Huakang Pharmaceutical Product
    Table 96. Meidakang Huakang Pharmaceutical Recent Development
    Table 97. Shandong Kongfu Pharmaceutical Corporation Information
    Table 98. Shandong Kongfu Pharmaceutical Description and Business Overview
    Table 99. Shandong Kongfu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Shandong Kongfu Pharmaceutical Product
    Table 101. Shandong Kongfu Pharmaceutical Recent Development
    Table 102. SL PHARM Corporation Information
    Table 103. SL PHARM Description and Business Overview
    Table 104. SL PHARM Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. SL PHARM Product
    Table 106. SL PHARM Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Pomalidomide Customers List
    Table 110. Pomalidomide Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pomalidomide Product Picture
    Figure 2. Global Pomalidomide Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Pomalidomide Market Size 2017-2028 (US$ Million)
    Figure 4. Global Pomalidomide Sales 2017-2028 (K Pcs)
    Figure 5. United States Pomalidomide Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Pomalidomide Market Size 2017-2028 (US$ Million)
    Figure 7. United States Pomalidomide Sales 2017-2028 (K Pcs)
    Figure 8. United States Pomalidomide Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Pomalidomide Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Pomalidomide Report Years Considered
    Figure 11. Product Picture of 1mg Tables
    Figure 12. Product Picture of 2mg Tables
    Figure 13. Product Picture of 4mg Tables
    Figure 14. Global Pomalidomide Market Share by Type in 2022 & 2028
    Figure 15. Global Pomalidomide Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Pomalidomide Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Pomalidomide Sales by Type (2017-2028) & (K Pcs)
    Figure 18. Global Pomalidomide Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Pomalidomide Price by Type (2017-2028) & (USD/Pcs)
    Figure 20. United States Pomalidomide Market Share by Type in 2022 & 2028
    Figure 21. United States Pomalidomide Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Pomalidomide Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Pomalidomide Sales by Type (2017-2028) & (K Pcs)
    Figure 24. United States Pomalidomide Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Pomalidomide Price by Type (2017-2028) & (USD/Pcs)
    Figure 26. Product Picture of Hospital
    Figure 27. Product Picture of Drug Center
    Figure 28. Product Picture of Clinic
    Figure 29. Product Picture of Other
    Figure 30. Global Pomalidomide Market Share by Application in 2022 & 2028
    Figure 31. Global Pomalidomide Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Pomalidomide Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Pomalidomide Sales by Application (2017-2028) & (K Pcs)
    Figure 34. Global Pomalidomide Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Pomalidomide Price by Application (2017-2028) & (USD/Pcs)
    Figure 36. United States Pomalidomide Market Share by Application in 2022 & 2028
    Figure 37. United States Pomalidomide Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Pomalidomide Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Pomalidomide Sales by Application (2017-2028) & (K Pcs)
    Figure 40. United States Pomalidomide Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Pomalidomide Price by Application (2017-2028) & (USD/Pcs)
    Figure 42. North America Pomalidomide Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 43. North America Pomalidomide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Pomalidomide Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. Europe Pomalidomide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Pomalidomide Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 54. Asia-Pacific Pomalidomide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Pomalidomide Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 66. Latin America Pomalidomide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Pomalidomide Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 71. Middle East & Africa Pomalidomide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Pomalidomide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Pomalidomide Value Chain
    Figure 76. Pomalidomide Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed